-
-
-
-
-
-
-
PDS Biotech amends phase 3 trial protocol to potentially speed approval
-
-
-
-
-
-
-
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
PDS Biotechnology Corp (PDSB) PT Lowered to $13 at H.C. Wainwright
-
-
-
-
-
-
-
PDS Biotechnology (PDSB) Tops Q2 EPS by 10c
-
-
-
-
-
-
-
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
-
-
-
-
-
-
-
PDS Biotechnology (PDSB) Misses Q2 EPS by 2c
-
-
-
-
-
-
-
PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter 2022 Financial Results
-
1,223,001 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

